Global Iloprost Drugs Market Growth (Status and Outlook) 2025-2031

January 2025 | 80 pages | ID: GB14169B7EBDEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Iloprost Drugs market size is predicted to grow from US$ 85.3 million in 2025 to US$ 77.1 million in 2031; it is expected to grow at a CAGR of -1.7% from 2025 to 2031.

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues.

North America is estimated to have a major share in the global market with 75%.

LPI (LP Information)' newest research report, the “Iloprost Drugs Industry Forecast” looks at past sales and reviews total world Iloprost Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Iloprost Drugs sales for 2025 through 2031. With Iloprost Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iloprost Drugs industry.

This Insight Report provides a comprehensive analysis of the global Iloprost Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Iloprost Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iloprost Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iloprost Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iloprost Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Iloprost Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Inhaled
• Intravenous

Segmentation by Application:

• Hospital
• Clinic

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Actelion (J & J)
• Bayer AG

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Iloprost Drugs Market Size (2020-2031)
  2.1.2 Iloprost Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Iloprost Drugs by Country/Region (2020, 2024 & 2031)
2.2 Iloprost Drugs Segment by Type
  2.2.1 Inhaled
  2.2.2 Intravenous
2.3 Iloprost Drugs Market Size by Type
  2.3.1 Iloprost Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Iloprost Drugs Market Size Market Share by Type (2020-2025)
2.4 Iloprost Drugs Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
2.5 Iloprost Drugs Market Size by Application
  2.5.1 Iloprost Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Iloprost Drugs Market Size Market Share by Application (2020-2025)

3 ILOPROST DRUGS MARKET SIZE BY PLAYER

3.1 Iloprost Drugs Market Size Market Share by Player
  3.1.1 Global Iloprost Drugs Revenue by Player (2020-2025)
  3.1.2 Global Iloprost Drugs Revenue Market Share by Player (2020-2025)
3.2 Global Iloprost Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ILOPROST DRUGS BY REGION

4.1 Iloprost Drugs Market Size by Region (2020-2025)
4.2 Global Iloprost Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Iloprost Drugs Market Size Growth (2020-2025)
4.4 APAC Iloprost Drugs Market Size Growth (2020-2025)
4.5 Europe Iloprost Drugs Market Size Growth (2020-2025)
4.6 Middle East & Africa Iloprost Drugs Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Iloprost Drugs Market Size by Country (2020-2025)
5.2 Americas Iloprost Drugs Market Size by Type (2020-2025)
5.3 Americas Iloprost Drugs Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Iloprost Drugs Market Size by Region (2020-2025)
6.2 APAC Iloprost Drugs Market Size by Type (2020-2025)
6.3 APAC Iloprost Drugs Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Iloprost Drugs Market Size by Country (2020-2025)
7.2 Europe Iloprost Drugs Market Size by Type (2020-2025)
7.3 Europe Iloprost Drugs Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Iloprost Drugs by Region (2020-2025)
8.2 Middle East & Africa Iloprost Drugs Market Size by Type (2020-2025)
8.3 Middle East & Africa Iloprost Drugs Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ILOPROST DRUGS MARKET FORECAST

10.1 Global Iloprost Drugs Forecast by Region (2026-2031)
  10.1.1 Global Iloprost Drugs Forecast by Region (2026-2031)
  10.1.2 Americas Iloprost Drugs Forecast
  10.1.3 APAC Iloprost Drugs Forecast
  10.1.4 Europe Iloprost Drugs Forecast
  10.1.5 Middle East & Africa Iloprost Drugs Forecast
10.2 Americas Iloprost Drugs Forecast by Country (2026-2031)
  10.2.1 United States Market Iloprost Drugs Forecast
  10.2.2 Canada Market Iloprost Drugs Forecast
  10.2.3 Mexico Market Iloprost Drugs Forecast
  10.2.4 Brazil Market Iloprost Drugs Forecast
10.3 APAC Iloprost Drugs Forecast by Region (2026-2031)
  10.3.1 China Iloprost Drugs Market Forecast
  10.3.2 Japan Market Iloprost Drugs Forecast
  10.3.3 Korea Market Iloprost Drugs Forecast
  10.3.4 Southeast Asia Market Iloprost Drugs Forecast
  10.3.5 India Market Iloprost Drugs Forecast
  10.3.6 Australia Market Iloprost Drugs Forecast
10.4 Europe Iloprost Drugs Forecast by Country (2026-2031)
  10.4.1 Germany Market Iloprost Drugs Forecast
  10.4.2 France Market Iloprost Drugs Forecast
  10.4.3 UK Market Iloprost Drugs Forecast
  10.4.4 Italy Market Iloprost Drugs Forecast
  10.4.5 Russia Market Iloprost Drugs Forecast
10.5 Middle East & Africa Iloprost Drugs Forecast by Region (2026-2031)
  10.5.1 Egypt Market Iloprost Drugs Forecast
  10.5.2 South Africa Market Iloprost Drugs Forecast
  10.5.3 Israel Market Iloprost Drugs Forecast
  10.5.4 Turkey Market Iloprost Drugs Forecast
10.6 Global Iloprost Drugs Forecast by Type (2026-2031)
10.7 Global Iloprost Drugs Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Iloprost Drugs Forecast

11 KEY PLAYERS ANALYSIS

11.1 Actelion (J & J)
  11.1.1 Actelion (J & J) Company Information
  11.1.2 Actelion (J & J) Iloprost Drugs Product Offered
  11.1.3 Actelion (J & J) Iloprost Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Actelion (J & J) Main Business Overview
  11.1.5 Actelion (J & J) Latest Developments
11.2 Bayer AG
  11.2.1 Bayer AG Company Information
  11.2.2 Bayer AG Iloprost Drugs Product Offered
  11.2.3 Bayer AG Iloprost Drugs Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer AG Main Business Overview
  11.2.5 Bayer AG Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Iloprost Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Iloprost Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Inhaled
Table 4. Major Players of Intravenous
Table 5. Iloprost Drugs Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Iloprost Drugs Market Size byType (2020-2025) & ($ millions)
Table 7. Global Iloprost Drugs Market Size Market Share byType (2020-2025)
Table 8. Iloprost Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Iloprost Drugs Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Iloprost Drugs Market Size Market Share by Application (2020-2025)
Table 11. Global Iloprost Drugs Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Iloprost Drugs Revenue Market Share by Player (2020-2025)
Table 13. Iloprost Drugs Key Players Head office and Products Offered
Table 14. Iloprost Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Iloprost Drugs Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Iloprost Drugs Market Size Market Share by Region (2020-2025)
Table 19. Global Iloprost Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Iloprost Drugs Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Iloprost Drugs Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Iloprost Drugs Market Size Market Share by Country (2020-2025)
Table 23. Americas Iloprost Drugs Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Iloprost Drugs Market Size Market Share byType (2020-2025)
Table 25. Americas Iloprost Drugs Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Iloprost Drugs Market Size Market Share by Application (2020-2025)
Table 27. APAC Iloprost Drugs Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Iloprost Drugs Market Size Market Share by Region (2020-2025)
Table 29. APAC Iloprost Drugs Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Iloprost Drugs Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Iloprost Drugs Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Iloprost Drugs Market Size Market Share by Country (2020-2025)
Table 33. Europe Iloprost Drugs Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Iloprost Drugs Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Iloprost Drugs Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Iloprost Drugs Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Iloprost Drugs Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Iloprost Drugs
Table 39. Key Market Challenges & Risks of Iloprost Drugs
Table 40. Key IndustryTrends of Iloprost Drugs
Table 41. Global Iloprost Drugs Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Iloprost Drugs Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Iloprost Drugs Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Iloprost Drugs Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Actelion (J & J) Details, CompanyType, Iloprost Drugs Area Served and Its Competitors
Table 46. Actelion (J & J) Iloprost Drugs Product Offered
Table 47. Actelion (J & J) Iloprost Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Actelion (J & J) Main Business
Table 49. Actelion (J & J) Latest Developments
Table 50. Bayer AG Details, CompanyType, Iloprost Drugs Area Served and Its Competitors
Table 51. Bayer AG Iloprost Drugs Product Offered
Table 52. Bayer AG Iloprost Drugs Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Bayer AG Main Business
Table 54. Bayer AG Latest Developments



LIST OFFIGURES

Figure 1. Iloprost Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Iloprost Drugs Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Iloprost Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Iloprost Drugs Sales Market Share by Country/Region (2024)
Figure 8. Iloprost Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Iloprost Drugs Market Size Market Share byType in 2024
Figure 10. Iloprost Drugs in Hospital
Figure 11. Global Iloprost Drugs Market: Hospital (2020-2025) & ($ millions)
Figure 12. Iloprost Drugs in Clinic
Figure 13. Global Iloprost Drugs Market: Clinic (2020-2025) & ($ millions)
Figure 14. Global Iloprost Drugs Market Size Market Share by Application in 2024
Figure 15. Global Iloprost Drugs Revenue Market Share by Player in 2024
Figure 16. Global Iloprost Drugs Market Size Market Share by Region (2020-2025)
Figure 17. Americas Iloprost Drugs Market Size 2020-2025 ($ millions)
Figure 18. APAC Iloprost Drugs Market Size 2020-2025 ($ millions)
Figure 19. Europe Iloprost Drugs Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Iloprost Drugs Market Size 2020-2025 ($ millions)
Figure 21. Americas Iloprost Drugs Value Market Share by Country in 2024
Figure 22. United States Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Iloprost Drugs Market Size Market Share by Region in 2024
Figure 27. APAC Iloprost Drugs Market Size Market Share byType (2020-2025)
Figure 28. APAC Iloprost Drugs Market Size Market Share by Application (2020-2025)
Figure 29. China Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 33. India Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Iloprost Drugs Market Size Market Share by Country in 2024
Figure 36. Europe Iloprost Drugs Market Size Market Share byType (2020-2025)
Figure 37. Europe Iloprost Drugs Market Size Market Share by Application (2020-2025)
Figure 38. Germany Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 39.France Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Iloprost Drugs Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Iloprost Drugs Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Iloprost Drugs Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Iloprost Drugs Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 52. APAC Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 53. Europe Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 55. United States Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 56. Canada Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 57. Mexico Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 58. Brazil Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 59. China Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 60. Japan Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 61. Korea Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 63. India Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 64. Australia Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 65. Germany Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 66.France Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 67. UK Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 68. Italy Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 69. Russia Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 70. Egypt Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 71. South Africa Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 72. Israel Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 73.Turkey Iloprost Drugs Market Size 2026-2031 ($ millions)
Figure 74. Global Iloprost Drugs Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Iloprost Drugs Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Iloprost Drugs Market Size 2026-2031 ($ millions)